Predicting the Impact of Diffuse Alveolar Damage through Open Lung Biopsy in Acute Respiratory Distress Syndrome-The PREDATOR Study.

acute respiratory distress syndrome acute respiratory failure diffuse alveolar damage

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
11 Jun 2019
Historique:
received: 30 04 2019
revised: 24 05 2019
accepted: 31 05 2019
entrez: 20 6 2019
pubmed: 20 6 2019
medline: 20 6 2019
Statut: epublish

Résumé

The aim of this retrospective and international study is to identify those clinical variables associated with diffuse alveolar damage (DAD), and to explore the impact of DAD on hospital mortality risk. Inclusion criteria were: adult patients with acute respiratory distress syndrome (ARDS) undergoing open lung biopsy (OLB) during their intensive care unit (ICU) management. The main end-points were: DAD and hospital mortality. In the training (

Identifiants

pubmed: 31212621
pii: jcm8060829
doi: 10.3390/jcm8060829
pmc: PMC6616523
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Surgery. 2008 Mar;143(3):426-33
pubmed: 18291264
J Crit Care. 2009 Mar;24(1):122-8
pubmed: 19272548
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Am J Respir Cell Mol Biol. 2011 May;44(5):725-38
pubmed: 21531958
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Shock. 2013 Mar;39(3):255-60
pubmed: 23364437
Springerplus. 2013 May 14;2(1):222
pubmed: 23853744
PLoS One. 2014 Feb 27;9(2):e90426
pubmed: 24587357
Intensive Care Med. 2014 Jun;40(6):769-87
pubmed: 24667919
Ann Thorac Surg. 2014 Oct;98(4):1254-60
pubmed: 25069683
Intensive Care Med. 2015 Jan;41(1):1-11
pubmed: 25354475
Intensive Care Med. 2015 Feb;41(2):222-30
pubmed: 25476984
Chest. 2015 Jan;147(1):7-8
pubmed: 25560852
N Engl J Med. 2015 Feb 19;372(8):747-55
pubmed: 25693014
Chest. 2015 Oct;148(4):1073-1082
pubmed: 25950989
Crit Care. 2015 May 15;19:228
pubmed: 25981598
Ann Am Thorac Soc. 2015 Aug;12(8):1226-30
pubmed: 26065712
Intensive Care Med. 2016 Mar;42(3):411-414
pubmed: 26130322
Intensive Care Med. 2015 Nov;41(11):1921-30
pubmed: 26385863
Transl Res. 2016 Mar;169:102-11
pubmed: 26687392
Ann Transl Med. 2016 Jan;4(2):30
pubmed: 26889483
Chest. 2016 May;149(5):1155-64
pubmed: 26896701
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
Intensive Care Med. 2016 May;42(5):674-685
pubmed: 27007111
J Crit Care. 2016 Aug;34:31-2
pubmed: 27288606
Am J Respir Crit Care Med. 2017 Feb 1;195(3):331-338
pubmed: 27513822
Intensive Care Med. 2016 Oct;42(10):1567-1575
pubmed: 27620287
Intensive Care Med. 2016 Oct;42(10):1597-1600
pubmed: 27637717
Curr Opin Crit Care. 2017 Feb;23(1):24-29
pubmed: 27906708
Intensive Care Med. 2017 Feb;43(2):200-208
pubmed: 28108768
Ann Am Thorac Soc. 2017 Jun;14(6):844-850
pubmed: 28570160
Ann Transl Med. 2017 Jul;5(14):284
pubmed: 28828359
Rev Bras Ter Intensiva. 2017 Jul-Sep;29(3):354-363
pubmed: 28977098
Crit Care. 2017 Oct 20;21(1):254
pubmed: 29052522
Korean J Intern Med. 2018 May;33(3):532-540
pubmed: 29088909
Am J Respir Crit Care Med. 2018 Apr 15;197(8):1027-1035
pubmed: 29253353
Ann Transl Med. 2017 Dec;5(24):484
pubmed: 29299446
Thorax. 2018 May;73(5):439-445
pubmed: 29477989
Med Intensiva. 2019 Apr;43(3):139-146
pubmed: 29501285
Crit Care Med. 2018 Jun;46(6):907-914
pubmed: 29521713
PLoS One. 2018 May 25;13(5):e0196795
pubmed: 29799835
Arch Bronconeumol. 2019 Jan;55(1):31-37
pubmed: 29853259
Methods Mol Biol. 2018;1809:341-350
pubmed: 29987799
Lancet Respir Med. 2018 Sep;6(9):691-698
pubmed: 30078618
Intensive Care Med. 2019 May 13;:null
pubmed: 31087114
Anesthesiology. 1998 Apr;88(4):935-44
pubmed: 9579502

Auteurs

Pablo Cardinal-Fernandez (P)

Hospital Universitario HM Sanchinarro, 28050 Madrid, Spain. pablocardinal@hotmail.com.
Fundación HM, 28050 Madrid, Spain. pablocardinal@hotmail.com.

Guillermo Ortiz (G)

Universidad del Bosque, Bogotá #131a2, Colombia. ortiz_guillermo@hotmail.com.
Universidad de Barcelona, 08007 Barcelona, Spain. ortiz_guillermo@hotmail.com.

Chih-Hao Chang (CH)

Chang Gung Memorial Hospital, Taoyuan 33005, Taiwan. ma7384@cgmh.org.tw.

Kuo-Chin Kao (KC)

Chang Gung Memorial Hospital, Taoyuan 33005, Taiwan. kck0502@cgmh.org.tw.

Emmanuelle Bertreau (E)

Réanimation Médicale Hôpital de la Croix Rousse, 69004 Lyon, France. emmanuelle.bertreau@chu-lyon.fr.

Carole Philipponnet (C)

Réanimation Médicale, F63000 Clermont-Ferrand, France. cphilipponnet@chu-clermontferrand.fr.

Víctor Manuel Casero-Alonso (VM)

Statistic Area, Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain. VictorManuel.Casero@uclm.es.

Bertrand Souweine (B)

Réanimation Médicale, F63000 Clermont-Ferrand, France. bsouweine@chu-clermontferrand.fr.

Emmanuel Charbonney (E)

Centre de Recherche Hôpital du Sacré-Cœur de Montréal (HSCM), 5400 boul. Gouin Ouest, Montréal, QC H4J 1C5, Canada. emmanuel.charbonney@umontreal.ca.

Claude Guérin (C)

Réanimation Médicale Hôpital de la Croix Rousse, 69004 Lyon, France. claude.guerin@chu-lyon.fr.
Lyon East Faculty of Medicine, University of Lyon, 69100 Lyon, France. claude.guerin@chu-lyon.fr.
INSERM, 955 Créteil, France. claude.guerin@chu-lyon.fr.
Hospices Civils de Lyon, 69003 Lyon, France. claude.guerin@chu-lyon.fr.

Classifications MeSH